Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

RecruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

November 1, 2029

Study Completion Date

November 1, 2029

Conditions
Pancreatic Carcinoma
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (2)

15232

NOT_YET_RECRUITING

University of Pittsburgh, Pittsburgh

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT06271291 - Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts | Biotech Hunter | Biotech Hunter